Tumor targeting properties were evaluated in BALB/c nude mice with subcutaneous LS174T-PSMA and LS174T wildtype tumors using μSPECT/CT imaging, fluorescence imaging, and biodistribution studies after dissection. This evidence concerns the gene FOLH1 and neoplasm.